And they clearing see IMU as very undervalued.
4 out of 7 complete responses. FFS!
As far as Vaxinia teaming up with a chemo drug that matter has been addressed in a company video some time ago. It’s a ph1 trial. They learn and modify as they go to optimise the drug. They know the patients do better if they have been pretreated with chemo for a month. This move is exactly the same as they did with IL2 in the Acee-Cel trail. They are optimising the process.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.2¢ | $304.8K | 23.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 57 | 13718532 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 5374446 | 13 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |